Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Strokeļ¼Longterm Outcome (OPENS-3L)
Status:
Recruiting
Trial end date:
2025-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term efficacy and safety of Normobaric
Hyperoxia combined with intravenous thrombolysis for acute ischemic stroke.
Phase:
Phase 3
Details
Lead Sponsor:
Ji Xunming,MD,PhD
Collaborators:
Affiliated Hospital of Nantong University Beijing Friendship Hospital Beijing Shijitan Hospital, Capital Medical University Beijing Tongren Hospital Changsha Central Hospital Guizhou Provincial People's Hospital Jining First People's Hospital Linyi People's Hospital Nanyang Central Hospital People's Hospital of Beijing Daxing District Rizhao People's Hospital Second Affiliated Hospital of Nanchang University Shandong Provincial Hospital The Affiliated Hospital of Xuzhou Medical University The First Affiliated Hospital of Soochow University The First Affiliated Hospital of Zhengzhou University The Second Hospital of Anhui Medical University Tianjin Huanhu Hospital Zhumadian Central Hospital